Triantafyllos Tafas

Papers

1

Total Citations

116

H-Index

1

About

Dr. Triantafyllos Tafas has pioneered transformative technologies in cancer diagnostics, with a primary focus on liquid biopsy and automated cellular imaging. His landmark 2008 paper, "Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope," has garnered 116 citations and introduced a highly sensitive, automated method for identifying and enumerating circulating tumour cells (CTCs) in blood samples from prostate, colorectal, and ovarian cancer patients. This work established a non-invasive approach to cancer detection and monitoring, significantly advancing the field of precision oncology. Dr. Tafas’s contributions have enabled more accurate, high-throughput analysis of rare cells, impacting both clinical research and patient care. His innovative use of automated scanning fluorescence microscopy set a new standard for CTC detection, demonstrating remarkable specificity and sensitivity compared to healthy controls. Through these achievements, Dr. Tafas has become a key figure in the development of minimally invasive cancer diagnostics, with his research continuing to influence the design of next-generation liquid biopsy platforms.

Research Focus

Key Achievements

1
H-Index
1
Papers
116
Total Citations
116
Avg Citations/Paper
🏆 Most Cited Paper
Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope
116 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 10

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago